YouTube video by Bloomberg Television

The company claims that its model achieved state of the art on specific metrics.

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development

Latent Labs founder Simon Kohl, a former member of the internet giant’s DeepMind team, has a new target

Simon Kohl aims to capitalise on his experience with Nobel-recognised AlphaFold protein prediction system